Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Gynaecol Oncol ; 35(1): 20-5, 2014.
Article in English | MEDLINE | ID: mdl-24654456

ABSTRACT

The aim of this study was to characterize infiltrating immune cells in cervical stroma biopsy samples from patients diagnosed with cervical intraepithelial neoplasias (CINs) who were treated with IFN-alpha 2b. The authors studied 13 volunteers who were diagnosed with Cervical intraepithelial neoplasia CIN II or III and who received intra-lesional treatment with IFN-alpha 2b. They collected pre- and post-treatment biopsies from each patient. They also examined the slides under a common optical microscope with a X400 lens for biopsy sample sections that were labeled with immunohistochemistry for T lymphocyte, B lymphocyte, natural killer cell, macrophage, iNOS, and perforin markers. The presence of immune response cells in the lesion was observed after treatment with intralesional IFN-alpha 2b in patients with CIN II/III changes, a reduction in CD4+ and CD8+ T lymphocyte infiltration in the women who responded well to treatment. However, there was a significant increase in these markers in samples from women who did not respond to treatment. Nonetheless, immunotherapy with IFN-alpha 2b administered intralesionally in patients with CIN II/III yields favorable results in patients who do not smoke.


Subject(s)
Interferon-alpha/therapeutic use , Uterine Cervical Dysplasia/drug therapy , Uterine Cervical Dysplasia/immunology , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/immunology , Adult , Antigens, CD/immunology , Female , Humans , Injections, Intralesional , Interferon alpha-2 , Middle Aged , Neoplasm Grading , Prospective Studies , Recombinant Proteins/therapeutic use , Treatment Failure , Uterine Cervical Neoplasms/pathology , Uterine Cervical Dysplasia/pathology
2.
Clin Exp Obstet Gynecol ; 40(2): 198-202, 2013.
Article in English | MEDLINE | ID: mdl-23971237

ABSTRACT

AIM: The purpose of this study was to identify placental and umbilical cord macroscopic changes and correlate them to maternal and fetal clinical events in hypertensive disorders of pregnancy (HDP). MATERIALS AND METHODS: The authors examined 150 placentas, 30 from each HDP group, totaling 120, and 30 from the control group. All placentas and umbilical cords were examined, recorded, and photographed. RESULTS: The mean placental weight in the control group (526.3 +/- 95.6 g) was greater than in the HDP (435.5 +/- 43.1 g). Calciphylaxis was the most common macroscopic change found in the control and HDP groups in 27 (90%) and 118 cases (98.3%), respectively. DISCUSSION: Pregnant women with HDP were relatively younger. In addition, due to low blood flow seen in HDP, the macroscopic changes found included lower placental weight, calciphylaxis in the maternal surface, and fibrin in the fetal surface. Because of all complications associated, most women with HDP had preterm infants who developed respiratory problems and had shorter umbilical cords.


Subject(s)
Hypertension, Pregnancy-Induced/pathology , Placenta/pathology , Umbilical Cord/pathology , Calciphylaxis/pathology , Female , Humans , Infant, Newborn , Infant, Premature , Infant, Premature, Diseases/pathology , Maternal Age , Organ Size , Pregnancy , Prospective Studies , Respiration Disorders/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...